Figure 1 (Figure1)
Lopinavir And Ritonavir Tablet, Film Coated
Product Images NDC 42385-934
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lopinavir And Ritonavir (NDC 42385-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel-200 mg/50 mg (Container Label (120's count))
This is a description of a medication called Lopinavir and Ritonavir Tablets, USP that is typically used to treat HIV. Each tablet contains 200mg of Lopinavir and 50mg of Ritonavir. The recommended storage is between 20°C to 25°C, and the medication should be dispensed in the original container or a tight container that is equivalent to USP. Additionally, the medication guide should be dispensed separately to each patient. The package insert should be consulted for full prescribing information. If the patient is using this product outside of the original container or the USP equivalent tight container for longer than 2 weeks, then it is not recommended, as exposure to high humidity could damage the product. The medication should not be accepted if the seal over the bottle opening is missing or broken. Pharmacies should not cover the Alert box and should dispense the Medication Guide separately. The medication is only available via prescription, and the expiration date should be checked before use. The product is manufactured for Laurus Generics Inc. in Berkeley Heights, NJ, USA. Created by Laurus Labs Limited in Visakhapatnam, India.*
Principal Display Panel-100 mg/25 mg (Container Label (60's count))
This text describes the composition, dosage, storage, and dispensing instructions for the pharmaceutical product called Lopinavir and Ritonavir Tablets. The tablets contain Lopinavir 100 mg and Ritonavir 25 mg. The recommended temperature for storage is between 20° to 25°C. Dispensing in the original container or USP equivalent tight container is recommended. The text also provides cautionary measures for the exposure of the product to high humidity outside the container. The product should not be used if the seal over the bottle opening is broken or missing. The text includes the manufacturer's details and alert messages for pharmacists and patients. It advises against taking medicines not recommended with Lopinavir and Ritonavir Tablets.*
Lopinavir-structure (Lopinavir Structure)
Ritonavir-structure (Ritonavir Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
